The need to search for new, alternative treatments for various diseases has prompted
scientists and physicians to focus their attention on regenerative medicine and broadly …

Bone fractures and segmental bone defects are a significant source of patient morbidity and
place a staggering economic burden on the healthcare system. The annual cost of treating …

Musculoskeletal disorders represent a major cause of disability and morbidity globally and
result in enormous costs for health and social care systems. Development of cell-based …

Mesenchymal stem/stromal cells (MSCs) have been carefully examined to have tremendous
potential in regenerative medicine. With their immunomodulatory and regenerative …

Human umbilical cord (UC) is a promising source of mesenchymal stem cells (MSCs). Apart
from their prominent advantages, such as a painless collection procedure and faster self …

Background The use and effectiveness of hematopoietic stem cell transplantation (HSCT)
are limited by lethal complications, ie, acute and chronic graft-versus-host disease (aGVHD …

Mesenchymal stem cells (MSCs) from bone marrow, adult organs and fetuses face the
disadvantages of invasive isolation, limited cell numbers and ethical constraints while …

Human umbilical cord blood (CB) is a potential source for mesenchymal stem cells (MSC)
capable of forming specific tissues, for example, bone, cartilage, or muscle. However …

Although accumulating evidence has linked mesenchymal stem cells (MSCs) with tumor
growth, the underlying mechanisms are poorly understood. Here, we demonstrated for the …

This review focuses on the therapeutic potential of stem cells harvested from the Wharton's
Jelly of the human umbilical cord. Recently, investigators have found that a potent stem cell …